Susana Ros
9PUBLICATIONS
92CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.Valentina Cutano, Shanade Dunn, Sungmi Park-Chouinard
|Apr 22, 2025
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer.Valentina Cutano, Ming Li Chia, Eleanor M Wigmore
|Dec 05, 2024
Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatment.Ming Li Chia, Flaviu Bulat, Adam Gaunt
|Feb 27, 2024
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.Emily C Erickson, Inchul You, Grace Perry
|Sep 19, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
|Sep 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.Mandy Lawson, Natalie Cureton, Susana Ros
Pageof 2
Frequent Collaborators
7 joint publications
Simon T Barry
6 joint publications
Stuart Williamson
5 joint publications
Lorna Hopcroft
4 joint publications
Elza DeBruin
4 joint publications
Larissa S Carnevalli
2 joint publications
Cath Eberlein
2 joint publications
Valentina Cutano
2 joint publications
Eleanor M Wigmore
2 joint publications
Jennifer Moss
2 joint publications
Kevin M Brindle
